Cargando…
Population-based pattern of medication use and prevalence of polypharmacy among patients with cardiovascular diseases: results of the Pars cohort study from Iran
BACKGROUND: Polypharmacy in patients with cardiovascular diseases (CVDs) has been linked to several adverse outcomes. This study aimed to investigate the pattern of medication use and prevalence of polypharmacy among CVDs patients in Iran. METHOD: We used the baseline data of the Pars cohort study (...
Autores principales: | Mohsenzadeh, Pooran, Ardekani, Ali, Poustchi, Hossein, Mohammadi, Zahra, Abdipour Mehrian, Seyed Reza, Bazrafshan Drissi, Hamed, Rahimian, Zahra, Taherifard, Erfan, Nabavizadeh, Ali, kamalipour, Alireza, Mesgarpour, Bita, Malekzadeh, Fatemeh, Molavi Vardanjani, Hossein |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9536013/ https://www.ncbi.nlm.nih.gov/pubmed/36203125 http://dx.doi.org/10.1186/s12872-022-02872-7 |
Ejemplares similares
-
The pattern of medication use, and determinants of the prevalence of polypharmacy among patients with a recent history of depressive disorder: results from the pars cohort study
por: Ghaed-Sharaf, Mehrnoosh, et al.
Publicado: (2022) -
Upper Normal Limit of Serum Alanine Aminotransferase and Its Association with Metabolic Risk Factors in Pars Cohort Study
por: Sehatpour, Faeze, et al.
Publicado: (2020) -
The prevalence of risk factors associated with non-communicable diseases in Afghan refugees in southern Iran: a cross-sectional study
por: Taherifard, Erfan, et al.
Publicado: (2021) -
Prevalence of age-related macular degeneration in Iran and its projections through 2050: a systematic review and meta-analysis
por: Roshanshad, Amirhossein, et al.
Publicado: (2023) -
Prevalence of Chronic Constipation and Its Associated Factors in Pars Cohort Study: A Study of 9000 Adults in Southern Iran
por: Moezi, Parinaz, et al.
Publicado: (2018)